Sargent Investment Group’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,918
| Closed | -$5.8K | – | 234 |
|
|
2024
Q4 | $5.8K | Sell |
10,918
-8,598
| -44% | -$4.57K | ﹤0.01% | 234 |
|
|
2024
Q3 | $8.7K | Hold |
19,516
| – | – | ﹤0.01% | 216 |
|
|
2024
Q2 | $51.7K | Sell |
19,516
-237
| -1% | -$628 | 0.01% | 214 |
|
|
2024
Q1 | $54.1K | Buy |
19,753
+1,549
| +9% | +$4.24K | 0.01% | 197 |
|
|
2023
Q4 | $44.2K | Sell |
18,204
-2,544
| -12% | -$6.18K | 0.01% | 206 |
|
|
2023
Q3 | $41.9K | Sell |
20,748
-85
| -0.4% | -$172 | 0.01% | 200 |
|
|
2023
Q2 | $61.5K | Buy |
20,833
+561
| +3% | +$1.66K | 0.01% | 194 |
|
|
2023
Q1 | $51.1K | Buy |
20,272
+5,150
| +34% | +$13K | 0.01% | 192 |
|
|
2022
Q4 | $47.9K | Buy |
15,122
+190
| +1% | +$602 | 0.01% | 189 |
|
|
2022
Q3 | $47K | Buy |
14,932
+4,652
| +45% | +$14.6K | 0.01% | 181 |
|
|
2022
Q2 | $31K | Buy |
+10,280
| New | +$31K | 0.01% | 181 |
|